Literature DB >> 27911101

In Vivo and Ex Vivo Evaluation of Inflammation and Apoptosis Induced after SMILE Procedures for Different Refractive Error Range.

Leonardo Mastropasqua1, Roberta Calienno1, Claudia Curcio2, Rodolfo Mastropasqua3, Mario Nubile1, Niccolò Salgari1, Manuela Lanzini1.   

Abstract

PURPOSE: To detect corneal inflammation and apoptosis induced after small incision lenticule extraction (SMILE) at different refractive corrections for moderate to high values of myopia.
METHODS: Fifty patients (50 eyes) suffering from medium to high myopia (spherical equivalent refraction from -3.75 to -10.00 diopters (D) with refractive astigmatism under -0.75 D) underwent SMILE in order to correct myopic error. In vivo evaluation was done by corneal confocal microscopy (IVCM) and ex vivo by immunohistochemistry. After surgery, all corneal lenticules were checked for regularity, entirety, and fixed in formalin for immunohistochemistry evaluation of apoptosis (TUNEL) and inflammation (CD11b) levels. Postoperative assessments took place during the first week and the first and third months after surgery. Patients returned for IVCM examination for analysis of the corneal stromal femtosecond laser treatment interfaces reflectivity.
RESULTS: No correlation was observed between treated myopic refractive error and number of CD11b+ and TUNEL+ cell in all analyzed extracted lenticules. IVCM at 1 week and 1 month of follow-up showed numerous reflective particles at the laser treatment interface with a moderate light scattering. In semi-quantitative analysis of reflectivity intensity at the laser interfaces, a statistical difference was evident only between 1 week and 1 month (p = 0.0213).
CONCLUSIONS: SMILE, as an innovative all-femto surgical procedure, results in a reduced tissue inflammation and apoptosis levels with a minimum tissue response, in terms of interface reflectivity, and there are no statistically significant differences among variable treated refractive error range.

Entities:  

Keywords:  Apoptosis; SMILE; immunohistochemistry; inflammation; refractive error

Mesh:

Year:  2016        PMID: 27911101     DOI: 10.1080/02713683.2016.1231324

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  4 in total

1.  Bioengineered Human Stromal Lenticule for Recombinant Human Nerve Growth Factor Release: A Potential Biocompatible Ocular Drug Delivery System.

Authors:  Leonardo Mastropasqua; Mario Nubile; Giuseppina Acerra; Nicola Detta; Letizia Pelusi; Manuela Lanzini; Simone Mattioli; Manuela Santalucia; Laura Pietrangelo; Marcello Allegretti; Harminder S Dua; Jodhbir S Mehta; Assunta Pandolfi; Domitilla Mandatori
Journal:  Front Bioeng Biotechnol       Date:  2022-06-23

2.  First Experience in Small Incision Lenticule Extraction with the Femto LDV Z8 and Lenticule Evaluation Using Scanning Electron Microscopy.

Authors:  Mengmeng Wang; Fengju Zhang; Christine Carole Copruz; Longhui Han
Journal:  J Ophthalmol       Date:  2020-09-26       Impact factor: 1.909

3.  Fluctuation in straylight measurements during the visual recovery phase after small incision lenticule extraction.

Authors:  Kelvin H Wan; Rachel W Y Tsui; Tommy C Y Chan
Journal:  Eye (Lond)       Date:  2019-08-09       Impact factor: 3.775

4.  Small Incision Lenticule Extraction for Correction of Myopia and Myopic Astigmatism: First 24-Hour Outcomes.

Authors:  Taixiang Liu; Tingting Dan; Yan Luo
Journal:  J Ophthalmol       Date:  2017-06-07       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.